Upadacitinib improves clinical outcomes in patients with moderate to severely active crohn's disease irrespective of previous failure to respond to biologics or conventional therapies
GASTROENTEROLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined